TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bioglan AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
193,095
|
151,483
|
121,092 |
| Financial expenses |
438
|
613
|
537 |
| Earnings before taxes |
25,576
|
19,944
|
7,072 |
| EBITDA |
28,286
|
24,832
|
10,982 |
| Total assets |
184,477
|
153,965
|
126,193 |
| Current assets |
124,170
|
99,835
|
81,387 |
| Current liabilities |
77,332
|
64,081
|
52,255 |
| Equity capital |
107,145
|
89,884
|
73,938 |
| - share capital |
1,948
|
2,015
|
2,005 |
| Employees (average) |
113
|
102
|
101 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.1%
|
58.4%
|
58.6% |
| Turnover per employee |
1,709
|
1,485
|
1,199 |
| Profit as a percentage of turnover |
13.2%
|
13.2%
|
5.8% |
| Return on assets (ROA) |
14.1%
|
13.4%
|
6.0% |
| Current ratio |
160.6%
|
155.8%
|
155.7% |
| Return on equity (ROE) |
23.9%
|
22.2%
|
9.6% |
| Change turnover |
46,622
|
29,768
|
13,284 |
| Change turnover % |
32%
|
24%
|
12% |
| Chg. No. of employees |
11
|
1
|
7 |
| Chg. No. of employees % |
11%
|
1%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.